A carregar...

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.

The development of familial and sporadic breast cancer is based on genetic alterations of tumour-suppressor genes, for which loss of heterozygosity (LOH) is one mechanism of gene inactivation. To investigate LOH of BRCA1 (17q21) and BRCA2 (13-q12-13) in sporadic breast cancer, polymerase chain react...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beckmann, M. W., Picard, F., An, H. X., van Roeyen, C. R., Dominik, S. I., Mosny, D. S., Schnürch, H. G., Bender, H. G., Niederacher, D.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1996
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2074503/
https://ncbi.nlm.nih.gov/pubmed/8630282
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!